title: Antibodies against human herpesvirus 8 in South African renal transplant recipients and blood donors.
abstract: OBJECTIVE
  To examine the seroprevalence of human herpesvirus 8 (HHV-8) antibodies in a selected group of renal transplant recipients and blood donors, in relation to various socio-demographic variables.
  
  
  METHODS
  Anonymised serum samples were obtained from 306 black donors attending blood donations at the SA National Blood Transfusion Service, Johannesburg, and 430 recipients of renal transplants at Johannesburg General Hospital, from 1998 to 1999.
  
  
  METHODS
  Serum samples were tested by indirect immunofluorescence assay to detect IgG antibodies against HHV-8. Crude and adjusted seroprevalence, and odds ratios were calculated to examine the relationship between antibodies to HHV-8 and age, sex, population, and risk group.
  
  
  RESULTS
  Adjusted HHV-8 seroprevalence at 'medium to high' antibody titres (at least 1:51,200) increased with age, from 2% (age 15-24; 95% CI=0.7-5.2) to 10% (age 45+; 95% CI=6.3-15.2). Whites had the lowest % adjusted seroprevalence (1.8; 95% CI:0.8-4.2), followed by blacks (7.4; 95% CI=5.1-10.8), Asians/Indians (9.5; 95% CI=3.6-22.9), and individuals of mixed race (12.5; 95% CI=4.5-30.2). Seroprevalence was not related to gender, or to occupation of blood donors. HHV-8 seroprevalence did not differ significantly between first-time blood donors, repeat donors, and transplant recipients (P=0.49). Transplant recipients had a greater proportion of persons with high HHV-8 antibody intensity; however, this difference was statistically not significant (P=0.08).
  
  
  CONCLUSIONS
  Blood donors and renal transplant patients had relatively high HHV-8 antibody titres. Given the strong association between HHV-8 seropostivity and the risk of developing Kaposi's sarcoma, it may be prudent in settings where HHV-8 seroprevalence is high to screen for HHV-8 in donated blood used for these immunocompromised individuals.
authors.affiliation: MRC/NHLS/CANSA/WITS Cancer Epidemiology Research Group, National Health Laboratory Services, PO Box 1038, Johannesburg, South Africa. Lara.Stein@nhls.ac.za
authors.forename: L
authors.initials: L
authors.lastname: Stein
authors.forename: H
authors.initials: H
authors.lastname: Carrara
authors.forename: R
authors.initials: R
authors.lastname: Norman
authors.forename: L
authors.initials: L
authors.lastname: Alagiozoglou
authors.forename: L
authors.initials: L
authors.lastname: Morris
authors.forename: F
authors.initials: F
authors.lastname: Sitas
mesh_terms: D000293:Adolescent; D000328:Adult; D000914:Antibodies, Viral / Q000097:blood*; D044383:Black People; D001782:Blood Donors; D005260:Female; D019288:Herpesvirus 8, Human / Q000276:immunology*; D006801:Humans; D016030:Kidney Transplantation; D008297:Male; D008875:Middle Aged; D015995:Prevalence; D012514:Sarcoma, Kaposi / Q000453:epidemiology* / Q000208:ethnology / Q000821:virology; D016036:Seroepidemiologic Studies; D013019:South Africa / Q000453:epidemiology; D044465:White People
chemical_list: D000914:Antibodies, Viral